A genetics company committed to providing genetic analysis products and services that translate genomic science into superior solutions for the biomedical research, molecular medicine, agricultural, and non-invasive prenatal testing markets.


Updates from The Motley Fool

Latest updates on Sequenom from Fool.com.


Stock Performance

SQNM vs. S&P 500 | 2 Year Performance
View Interactive SQNM Charts
Sponsored by

Key Data Points

Primary metrics and data points about Sequenom.
Current Price: $2.38
Prev Close: $2.38
Open: $2.38
Bid: $2.38
Ask: $2.39
Day's Range: $2.38 - $2.39
52wk Range: $0.82 - $2.53
Volume: 1,565,825
Avg Vol 3,057,734
Market Cap: $282.80M
P/E (ttm): -6.83
EPS (ttm): -$0.35
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Sequenom.
CAPS Rating 2 out of 5
 
637 Outperform
55 Underperform
CAPS All Stars
 
107 Outperform
21 Underperform

How do you think Sequenom will perform against the market?



You pick for Sequenom is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dirk van den Boom, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Sequenom.

A genetics company committed to providing genetic analysis products and services that translate genomic science into superior solutions for the biomedical research, molecular medicine, agricultural, and non-invasive prenatal testing markets.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers